nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—Dihomo-gamma-linolenic acid—FABP7—malignant glioma	0.0333	0.808	CrCbGaD
Alprostadil—PTGIR—endothelium—malignant glioma	0.0246	0.104	CbGeAlD
Alprostadil—PTGIR—blood vessel—malignant glioma	0.0227	0.0955	CbGeAlD
Alprostadil—Fibrosis—Carmustine—malignant glioma	0.0202	0.0651	CcSEcCtD
Alprostadil—Hyperaemia—Carmustine—malignant glioma	0.0192	0.0616	CcSEcCtD
Alprostadil—Haemorrhage intracranial—Temozolomide—malignant glioma	0.0136	0.0438	CcSEcCtD
Alprostadil—PTGIR—brainstem—malignant glioma	0.0124	0.0522	CbGeAlD
Alprostadil—PTGIR—telencephalon—malignant glioma	0.011	0.0463	CbGeAlD
Alprostadil—SLCO3A1—retina—malignant glioma	0.0105	0.0444	CbGeAlD
Alprostadil—Cerebral haemorrhage—Carmustine—malignant glioma	0.0105	0.0336	CcSEcCtD
Alprostadil—PTGER1—central nervous system—malignant glioma	0.0101	0.0426	CbGeAlD
Alprostadil—Cerebral haemorrhage—Temozolomide—malignant glioma	0.0101	0.0324	CcSEcCtD
Alprostadil—ABCC5—retina—malignant glioma	0.00956	0.0403	CbGeAlD
Alprostadil—ABCC5—telencephalon—malignant glioma	0.00879	0.037	CbGeAlD
Alprostadil—Burning sensation—Carmustine—malignant glioma	0.00833	0.0268	CcSEcCtD
Alprostadil—Influenza-like symptoms—Temozolomide—malignant glioma	0.00783	0.0252	CcSEcCtD
Alprostadil—PTGIR—spinal cord—malignant glioma	0.0077	0.0325	CbGeAlD
Alprostadil—SLCO3A1—medulla oblongata—malignant glioma	0.00762	0.0321	CbGeAlD
Alprostadil—Injection site pain—Carmustine—malignant glioma	0.00709	0.0228	CcSEcCtD
Alprostadil—SLCO3A1—midbrain—malignant glioma	0.00697	0.0294	CbGeAlD
Alprostadil—ABCC5—medulla oblongata—malignant glioma	0.00691	0.0291	CbGeAlD
Alprostadil—SLCO2B1—telencephalon—malignant glioma	0.00688	0.029	CbGeAlD
Alprostadil—SLCO3A1—spinal cord—malignant glioma	0.0068	0.0286	CbGeAlD
Alprostadil—Accidental injury—Carmustine—malignant glioma	0.00654	0.021	CcSEcCtD
Alprostadil—ABCC5—midbrain—malignant glioma	0.00631	0.0266	CbGeAlD
Alprostadil—PTGIR—central nervous system—malignant glioma	0.00625	0.0263	CbGeAlD
Alprostadil—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00615	0.0198	CcSEcCtD
Alprostadil—PTGIR—cerebellum—malignant glioma	0.00611	0.0257	CbGeAlD
Alprostadil—Injection site reaction—Carmustine—malignant glioma	0.00575	0.0185	CcSEcCtD
Alprostadil—SLCO3A1—central nervous system—malignant glioma	0.00552	0.0232	CbGeAlD
Alprostadil—SLCO2A1—central nervous system—malignant glioma	0.00546	0.023	CbGeAlD
Alprostadil—Influenza like illness—Temozolomide—malignant glioma	0.00543	0.0174	CcSEcCtD
Alprostadil—SLCO2B1—medulla oblongata—malignant glioma	0.00541	0.0228	CbGeAlD
Alprostadil—SLCO3A1—cerebellum—malignant glioma	0.00539	0.0227	CbGeAlD
Alprostadil—Abnormal vision—Carmustine—malignant glioma	0.00505	0.0162	CcSEcCtD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS1—malignant glioma	0.00504	0.122	CrCbGaD
Alprostadil—Sepsis—Carmustine—malignant glioma	0.00502	0.0161	CcSEcCtD
Alprostadil—PTGIR—brain—malignant glioma	0.00496	0.0209	CbGeAlD
Alprostadil—ABCC5—cerebellum—malignant glioma	0.00488	0.0206	CbGeAlD
Alprostadil—Abnormal vision—Temozolomide—malignant glioma	0.00488	0.0157	CcSEcCtD
Alprostadil—Diabetes mellitus—Carmustine—malignant glioma	0.00483	0.0155	CcSEcCtD
Alprostadil—SLCO2B1—spinal cord—malignant glioma	0.00482	0.0203	CbGeAlD
Alprostadil—Swelling—Carmustine—malignant glioma	0.00476	0.0153	CcSEcCtD
Alprostadil—Injury—Carmustine—malignant glioma	0.00457	0.0147	CcSEcCtD
Alprostadil—Nasal congestion—Temozolomide—malignant glioma	0.00446	0.0143	CcSEcCtD
Alprostadil—SLCO3A1—brain—malignant glioma	0.00438	0.0184	CbGeAlD
Alprostadil—SLCO2A1—brain—malignant glioma	0.00434	0.0183	CbGeAlD
Alprostadil—ABCC5—brain—malignant glioma	0.00397	0.0167	CbGeAlD
Alprostadil—SLCO2B1—central nervous system—malignant glioma	0.00391	0.0165	CbGeAlD
Alprostadil—Hypokalaemia—Carmustine—malignant glioma	0.00382	0.0123	CcSEcCtD
Alprostadil—SLCO2B1—cerebellum—malignant glioma	0.00382	0.0161	CbGeAlD
Alprostadil—Hypokalaemia—Temozolomide—malignant glioma	0.00369	0.0119	CcSEcCtD
Alprostadil—ABCC4—central nervous system—malignant glioma	0.00346	0.0146	CbGeAlD
Alprostadil—Sweating increased—Temozolomide—malignant glioma	0.00342	0.011	CcSEcCtD
Alprostadil—Bronchitis—Temozolomide—malignant glioma	0.00337	0.0108	CcSEcCtD
Alprostadil—Hyperglycaemia—Carmustine—malignant glioma	0.00327	0.0105	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00326	0.0105	CcSEcCtD
Alprostadil—Pollakiuria—Temozolomide—malignant glioma	0.00324	0.0104	CcSEcCtD
Alprostadil—Renal failure—Carmustine—malignant glioma	0.00318	0.0102	CcSEcCtD
Alprostadil—Hyperglycaemia—Temozolomide—malignant glioma	0.00316	0.0102	CcSEcCtD
Alprostadil—Urinary tract infection—Carmustine—malignant glioma	0.00315	0.0101	CcSEcCtD
Alprostadil—SLCO2B1—brain—malignant glioma	0.0031	0.0131	CbGeAlD
Alprostadil—Urinary tract infection—Temozolomide—malignant glioma	0.00304	0.00977	CcSEcCtD
Alprostadil—Sinusitis—Temozolomide—malignant glioma	0.00293	0.00943	CcSEcCtD
Alprostadil—Haemoglobin—Carmustine—malignant glioma	0.00292	0.00938	CcSEcCtD
Alprostadil—Haemorrhage—Carmustine—malignant glioma	0.00291	0.00934	CcSEcCtD
Alprostadil—Hypoaesthesia—Carmustine—malignant glioma	0.00289	0.00929	CcSEcCtD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS2—malignant glioma	0.00288	0.07	CrCbGaD
Alprostadil—Haemoglobin—Temozolomide—malignant glioma	0.00282	0.00907	CcSEcCtD
Alprostadil—Haemorrhage—Temozolomide—malignant glioma	0.00281	0.00902	CcSEcCtD
Alprostadil—Visual impairment—Carmustine—malignant glioma	0.0028	0.009	CcSEcCtD
Alprostadil—Hypoaesthesia—Temozolomide—malignant glioma	0.00279	0.00898	CcSEcCtD
Alprostadil—Pharyngitis—Temozolomide—malignant glioma	0.00279	0.00895	CcSEcCtD
Alprostadil—Urethral disorder—Temozolomide—malignant glioma	0.00275	0.00884	CcSEcCtD
Alprostadil—ABCC4—brain—malignant glioma	0.00275	0.0116	CbGeAlD
Alprostadil—Visual impairment—Temozolomide—malignant glioma	0.00271	0.00869	CcSEcCtD
Alprostadil—Flushing—Carmustine—malignant glioma	0.0027	0.00866	CcSEcCtD
Alprostadil—Flushing—Temozolomide—malignant glioma	0.00261	0.00837	CcSEcCtD
Alprostadil—Erythema—Carmustine—malignant glioma	0.00253	0.00813	CcSEcCtD
Alprostadil—Back pain—Carmustine—malignant glioma	0.00245	0.00786	CcSEcCtD
Alprostadil—Erythema—Temozolomide—malignant glioma	0.00244	0.00785	CcSEcCtD
Alprostadil—Back pain—Temozolomide—malignant glioma	0.00236	0.0076	CcSEcCtD
Alprostadil—Anaemia—Carmustine—malignant glioma	0.00234	0.00751	CcSEcCtD
Alprostadil—Anaemia—Temozolomide—malignant glioma	0.00226	0.00726	CcSEcCtD
Alprostadil—Convulsion—Carmustine—malignant glioma	0.00219	0.00704	CcSEcCtD
Alprostadil—Hypertension—Carmustine—malignant glioma	0.00218	0.00702	CcSEcCtD
Alprostadil—Cough—Temozolomide—malignant glioma	0.00213	0.00685	CcSEcCtD
Alprostadil—Convulsion—Temozolomide—malignant glioma	0.00212	0.0068	CcSEcCtD
Alprostadil—Hypertension—Temozolomide—malignant glioma	0.00211	0.00678	CcSEcCtD
Alprostadil—Oedema—Carmustine—malignant glioma	0.00206	0.00663	CcSEcCtD
Alprostadil—Discomfort—Temozolomide—malignant glioma	0.00206	0.00661	CcSEcCtD
Alprostadil—Infection—Carmustine—malignant glioma	0.00205	0.00659	CcSEcCtD
Alprostadil—Dry mouth—Temozolomide—malignant glioma	0.00204	0.00654	CcSEcCtD
Alprostadil—Thrombocytopenia—Carmustine—malignant glioma	0.00202	0.00649	CcSEcCtD
Alprostadil—Tachycardia—Carmustine—malignant glioma	0.00201	0.00647	CcSEcCtD
Alprostadil—Oedema—Temozolomide—malignant glioma	0.002	0.00641	CcSEcCtD
Alprostadil—Infection—Temozolomide—malignant glioma	0.00198	0.00637	CcSEcCtD
Alprostadil—Thrombocytopenia—Temozolomide—malignant glioma	0.00195	0.00628	CcSEcCtD
Alprostadil—Skin disorder—Temozolomide—malignant glioma	0.00194	0.00623	CcSEcCtD
Alprostadil—Hypotension—Carmustine—malignant glioma	0.00193	0.0062	CcSEcCtD
Alprostadil—Hyperhidrosis—Temozolomide—malignant glioma	0.00193	0.0062	CcSEcCtD
Alprostadil—Pain—Carmustine—malignant glioma	0.00177	0.00567	CcSEcCtD
Alprostadil—Dyspepsia—Temozolomide—malignant glioma	0.00176	0.00564	CcSEcCtD
Alprostadil—Pain—Temozolomide—malignant glioma	0.00171	0.00548	CcSEcCtD
Alprostadil—Feeling abnormal—Carmustine—malignant glioma	0.0017	0.00547	CcSEcCtD
Alprostadil—Feeling abnormal—Temozolomide—malignant glioma	0.00164	0.00528	CcSEcCtD
Alprostadil—Abdominal pain—Carmustine—malignant glioma	0.00163	0.00524	CcSEcCtD
Alprostadil—Body temperature increased—Carmustine—malignant glioma	0.00163	0.00524	CcSEcCtD
Alprostadil—Abdominal pain—Temozolomide—malignant glioma	0.00158	0.00507	CcSEcCtD
Alprostadil—Body temperature increased—Temozolomide—malignant glioma	0.00158	0.00507	CcSEcCtD
Alprostadil—Asthenia—Carmustine—malignant glioma	0.00148	0.00476	CcSEcCtD
Alprostadil—Asthenia—Temozolomide—malignant glioma	0.00143	0.0046	CcSEcCtD
Alprostadil—Diarrhoea—Carmustine—malignant glioma	0.00141	0.00454	CcSEcCtD
Alprostadil—Pruritus—Temozolomide—malignant glioma	0.00141	0.00453	CcSEcCtD
Alprostadil—Dizziness—Carmustine—malignant glioma	0.00137	0.00439	CcSEcCtD
Alprostadil—Diarrhoea—Temozolomide—malignant glioma	0.00137	0.00439	CcSEcCtD
Alprostadil—Dizziness—Temozolomide—malignant glioma	0.00132	0.00424	CcSEcCtD
Alprostadil—Rash—Carmustine—malignant glioma	0.0013	0.00418	CcSEcCtD
Alprostadil—Dermatitis—Carmustine—malignant glioma	0.0013	0.00418	CcSEcCtD
Alprostadil—Headache—Carmustine—malignant glioma	0.00129	0.00415	CcSEcCtD
Alprostadil—Rash—Temozolomide—malignant glioma	0.00126	0.00404	CcSEcCtD
Alprostadil—Dermatitis—Temozolomide—malignant glioma	0.00126	0.00404	CcSEcCtD
Alprostadil—Headache—Temozolomide—malignant glioma	0.00125	0.00402	CcSEcCtD
Alprostadil—Nausea—Carmustine—malignant glioma	0.00123	0.00394	CcSEcCtD
Alprostadil—Nausea—Temozolomide—malignant glioma	0.00119	0.00381	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—NOTCH3—malignant glioma	0.000237	0.000577	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOTCH3—malignant glioma	0.000237	0.000577	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—F2—malignant glioma	0.000236	0.000575	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—FN1—malignant glioma	0.000236	0.000575	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FBXW7—malignant glioma	0.000233	0.000568	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FBXW7—malignant glioma	0.000233	0.000568	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000232	0.000565	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—BDKRB2—malignant glioma	0.000228	0.000557	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—BDKRB2—malignant glioma	0.000228	0.000557	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—F2—malignant glioma	0.000227	0.000554	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—F2—malignant glioma	0.000227	0.000554	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VEGFA—malignant glioma	0.000227	0.000553	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL2—malignant glioma	0.000227	0.000552	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CG—malignant glioma	0.000226	0.000551	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TERT—malignant glioma	0.000226	0.00055	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN2B—malignant glioma	0.000224	0.000546	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—EGF—malignant glioma	0.000223	0.000544	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PTPN11—malignant glioma	0.000222	0.000541	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000221	0.00054	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PDGFB—malignant glioma	0.00022	0.000537	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGFR1—malignant glioma	0.000219	0.000534	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AKT2—malignant glioma	0.000219	0.000534	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AKT2—malignant glioma	0.000219	0.000534	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CG—malignant glioma	0.000217	0.00053	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CG—malignant glioma	0.000217	0.00053	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HIF1A—malignant glioma	0.000216	0.000526	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HES1—malignant glioma	0.000214	0.000521	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PTPN11—malignant glioma	0.000214	0.000521	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PTPN11—malignant glioma	0.000214	0.000521	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NCOR1—malignant glioma	0.000212	0.000518	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOTCH2—malignant glioma	0.000212	0.000517	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOTCH2—malignant glioma	0.000212	0.000517	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000211	0.000513	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PIK3CD—malignant glioma	0.000211	0.000513	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CAV1—malignant glioma	0.000209	0.000509	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KNG1—malignant glioma	0.000208	0.000506	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KNG1—malignant glioma	0.000208	0.000506	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—AKT2—malignant glioma	0.000207	0.000504	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—KDR—malignant glioma	0.000206	0.000503	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000205	0.000499	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PDGFRA—malignant glioma	0.000203	0.000496	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AKT2—malignant glioma	0.000199	0.000485	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AKT2—malignant glioma	0.000199	0.000485	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—F2—malignant glioma	0.000199	0.000485	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FN1—malignant glioma	0.000199	0.000485	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CD—malignant glioma	0.000199	0.000484	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NTRK1—malignant glioma	0.000198	0.000483	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NTRK1—malignant glioma	0.000198	0.000483	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—BAD—malignant glioma	0.000196	0.000479	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOTCH1—malignant glioma	0.000194	0.000474	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTP1—malignant glioma	0.000194	0.000472	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—KRAS—malignant glioma	0.000193	0.00047	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CD—malignant glioma	0.000191	0.000466	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CD—malignant glioma	0.000191	0.000466	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CD80—malignant glioma	0.000191	0.000465	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CG—malignant glioma	0.00019	0.000464	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APC—malignant glioma	0.00019	0.000464	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAT—malignant glioma	0.000188	0.000459	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EGF—malignant glioma	0.000188	0.000458	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HLA-A—malignant glioma	0.000187	0.000457	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TERT—malignant glioma	0.000187	0.000457	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTPN11—malignant glioma	0.000187	0.000456	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP3—malignant glioma	0.000184	0.000449	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP3—malignant glioma	0.000184	0.000449	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000183	0.000447	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PIK3CB—malignant glioma	0.000183	0.000447	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PDGFB—malignant glioma	0.000183	0.000446	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN2B—malignant glioma	0.000182	0.000445	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN2B—malignant glioma	0.000182	0.000445	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGFR1—malignant glioma	0.000182	0.000443	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HIF1A—malignant glioma	0.000179	0.000437	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—BRAF—malignant glioma	0.000179	0.000436	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NCOR1—malignant glioma	0.000178	0.000434	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—RAF1—malignant glioma	0.000177	0.000432	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTK2—malignant glioma	0.000177	0.000432	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTK2—malignant glioma	0.000177	0.000432	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—PIK3CA—malignant glioma	0.000177	0.000432	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL8—malignant glioma	0.000176	0.00043	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL8—malignant glioma	0.000176	0.00043	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HES1—malignant glioma	0.000174	0.000424	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HES1—malignant glioma	0.000174	0.000424	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT2—malignant glioma	0.000174	0.000424	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—EGFR—malignant glioma	0.000173	0.000422	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CAV1—malignant glioma	0.000173	0.000422	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CB—malignant glioma	0.000173	0.000422	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NCOR1—malignant glioma	0.000173	0.000422	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NCOR1—malignant glioma	0.000173	0.000422	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TP53—malignant glioma	0.000171	0.000418	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—RAF1—malignant glioma	0.000171	0.000416	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—RAF1—malignant glioma	0.000171	0.000416	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2—malignant glioma	0.000169	0.000411	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2—malignant glioma	0.000169	0.000411	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000167	0.000408	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CD—malignant glioma	0.000167	0.000408	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CB—malignant glioma	0.000167	0.000406	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CB—malignant glioma	0.000167	0.000406	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PDGFRA—malignant glioma	0.000166	0.000404	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PDGFRA—malignant glioma	0.000166	0.000404	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000166	0.000404	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—KRAS—malignant glioma	0.000164	0.000399	CbGpPWpGaD
Alprostadil—ABCC5—Disease—BAD—malignant glioma	0.000163	0.000397	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOTCH1—malignant glioma	0.000161	0.000393	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SPP1—malignant glioma	0.000161	0.000392	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SPP1—malignant glioma	0.000161	0.000392	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL8—malignant glioma	0.00016	0.00039	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL8—malignant glioma	0.00016	0.00039	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF2—malignant glioma	0.00016	0.00039	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2—malignant glioma	0.000159	0.000388	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD80—malignant glioma	0.000158	0.000385	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APC—malignant glioma	0.000158	0.000385	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EGF—malignant glioma	0.000156	0.00038	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTPN11—malignant glioma	0.000155	0.000378	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000153	0.000374	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2—malignant glioma	0.000153	0.000373	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2—malignant glioma	0.000153	0.000373	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TERT—malignant glioma	0.000152	0.000372	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TERT—malignant glioma	0.000152	0.000372	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PIK3CA—malignant glioma	0.00015	0.000367	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MDM2—malignant glioma	0.00015	0.000365	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RAF1—malignant glioma	0.000149	0.000364	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PDGFB—malignant glioma	0.000149	0.000363	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PDGFB—malignant glioma	0.000149	0.000363	CbGpPWpGaD
Alprostadil—ABCC5—Disease—BRAF—malignant glioma	0.000148	0.000362	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGFR1—malignant glioma	0.000148	0.000361	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGFR1—malignant glioma	0.000148	0.000361	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ERBB2—malignant glioma	0.000148	0.00036	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HIF1A—malignant glioma	0.000146	0.000356	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HIF1A—malignant glioma	0.000146	0.000356	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CB—malignant glioma	0.000146	0.000355	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAV1—malignant glioma	0.000145	0.000354	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—AKT1—malignant glioma	0.000145	0.000353	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT2—malignant glioma	0.000144	0.000352	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CAV1—malignant glioma	0.000141	0.000344	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CAV1—malignant glioma	0.000141	0.000344	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL8—malignant glioma	0.00014	0.000341	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KDR—malignant glioma	0.000139	0.00034	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KDR—malignant glioma	0.000139	0.00034	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3CD—malignant glioma	0.000139	0.000338	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—AKT1—malignant glioma	0.000135	0.00033	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—malignant glioma	0.000135	0.000329	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—F2—malignant glioma	0.000134	0.000327	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—F2—malignant glioma	0.000134	0.000327	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FN1—malignant glioma	0.000134	0.000327	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FN1—malignant glioma	0.000134	0.000327	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CASP3—malignant glioma	0.000134	0.000327	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2—malignant glioma	0.000134	0.000326	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF2—malignant glioma	0.000133	0.000324	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—BAD—malignant glioma	0.000133	0.000323	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—BAD—malignant glioma	0.000133	0.000323	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CG—malignant glioma	0.000132	0.000322	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOTCH1—malignant glioma	0.000131	0.00032	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOTCH1—malignant glioma	0.000131	0.00032	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CD80—malignant glioma	0.000129	0.000314	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CD80—malignant glioma	0.000129	0.000314	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CG—malignant glioma	0.000128	0.000313	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APC—malignant glioma	0.000128	0.000313	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APC—malignant glioma	0.000128	0.000313	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CG—malignant glioma	0.000128	0.000313	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARG—malignant glioma	0.000128	0.000311	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EGF—malignant glioma	0.000127	0.00031	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EGF—malignant glioma	0.000127	0.00031	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—malignant glioma	0.000127	0.000309	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTPN11—malignant glioma	0.000126	0.000308	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTPN11—malignant glioma	0.000126	0.000308	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTEN—malignant glioma	0.000126	0.000307	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MDM2—malignant glioma	0.000124	0.000303	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RAF1—malignant glioma	0.000124	0.000302	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—AKT1—malignant glioma	0.000123	0.0003	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ERBB2—malignant glioma	0.000122	0.000299	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3CB—malignant glioma	0.000121	0.000295	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—BRAF—malignant glioma	0.000121	0.000294	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—BRAF—malignant glioma	0.000121	0.000294	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—malignant glioma	0.00012	0.000292	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT2—malignant glioma	0.000118	0.000287	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT2—malignant glioma	0.000118	0.000287	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—EGFR—malignant glioma	0.000117	0.000285	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—EGFR—malignant glioma	0.000117	0.000285	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CD—malignant glioma	0.000116	0.000283	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—KRAS—malignant glioma	0.000115	0.00028	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—malignant glioma	0.000114	0.000277	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CD—malignant glioma	0.000113	0.000275	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CD—malignant glioma	0.000113	0.000275	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—STAT3—malignant glioma	0.000113	0.000275	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PIK3CA—malignant glioma	0.000112	0.000273	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000112	0.000273	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—KRAS—malignant glioma	0.000111	0.00027	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—KRAS—malignant glioma	0.000111	0.00027	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF2—malignant glioma	0.000108	0.000264	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF2—malignant glioma	0.000108	0.000264	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CA—malignant glioma	0.000105	0.000257	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MYC—malignant glioma	0.000105	0.000255	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTEN—malignant glioma	0.000104	0.000255	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EGFR—malignant glioma	0.000102	0.00025	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TP53—malignant glioma	0.000102	0.000249	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CA—malignant glioma	0.000102	0.000248	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CA—malignant glioma	0.000102	0.000248	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CB—malignant glioma	0.000101	0.000247	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MDM2—malignant glioma	0.000101	0.000247	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MDM2—malignant glioma	0.000101	0.000247	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RAF1—malignant glioma	0.000101	0.000246	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RAF1—malignant glioma	0.000101	0.000246	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—malignant glioma	0.0001	0.000245	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ERBB2—malignant glioma	9.97e-05	0.000243	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ERBB2—malignant glioma	9.97e-05	0.000243	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CB—malignant glioma	9.84e-05	0.00024	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CB—malignant glioma	9.84e-05	0.00024	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—KRAS—malignant glioma	9.67e-05	0.000236	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL8—malignant glioma	9.46e-05	0.000231	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL8—malignant glioma	9.46e-05	0.000231	CbGpPWpGaD
Alprostadil—ABCC5—Disease—STAT3—malignant glioma	9.34e-05	0.000228	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AKT1—malignant glioma	9.14e-05	0.000223	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AKT1—malignant glioma	9.14e-05	0.000223	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CASP3—malignant glioma	9.05e-05	0.000221	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CASP3—malignant glioma	9.05e-05	0.000221	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2—malignant glioma	9.04e-05	0.00022	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2—malignant glioma	9.04e-05	0.00022	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CA—malignant glioma	8.88e-05	0.000217	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTEN—malignant glioma	8.75e-05	0.000213	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MYC—malignant glioma	8.68e-05	0.000212	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—AKT1—malignant glioma	8.62e-05	0.00021	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TP53—malignant glioma	8.59e-05	0.00021	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—malignant glioma	8.56e-05	0.000209	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—malignant glioma	8.56e-05	0.000209	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTEN—malignant glioma	8.51e-05	0.000207	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTEN—malignant glioma	8.51e-05	0.000207	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EGFR—malignant glioma	8.49e-05	0.000207	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AKT1—malignant glioma	8.3e-05	0.000202	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AKT1—malignant glioma	8.3e-05	0.000202	CbGpPWpGaD
Alprostadil—ABCC5—Disease—KRAS—malignant glioma	8.02e-05	0.000196	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—malignant glioma	7.68e-05	0.000187	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—malignant glioma	7.68e-05	0.000187	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STAT3—malignant glioma	7.61e-05	0.000185	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STAT3—malignant glioma	7.61e-05	0.000185	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3CA—malignant glioma	7.37e-05	0.00018	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT1—malignant glioma	7.26e-05	0.000177	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MYC—malignant glioma	7.07e-05	0.000172	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MYC—malignant glioma	7.07e-05	0.000172	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EGFR—malignant glioma	6.91e-05	0.000169	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EGFR—malignant glioma	6.91e-05	0.000169	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KRAS—malignant glioma	6.53e-05	0.000159	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KRAS—malignant glioma	6.53e-05	0.000159	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CA—malignant glioma	6.17e-05	0.00015	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT1—malignant glioma	6.02e-05	0.000147	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CA—malignant glioma	6e-05	0.000146	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CA—malignant glioma	6e-05	0.000146	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TP53—malignant glioma	5.81e-05	0.000142	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TP53—malignant glioma	5.81e-05	0.000142	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKT1—malignant glioma	5.04e-05	0.000123	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT1—malignant glioma	4.9e-05	0.00012	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT1—malignant glioma	4.9e-05	0.00012	CbGpPWpGaD
